Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Warner-Lambert GMP Conviction Plays Role In Neurontin Case

Executive Summary

Warner-Lambert's 1995 guilty plea related to good manufacturing practices compliance is an important factor in the Neurontin off-label promotion case settled by Pfizer on May 13
Advertisement

Related Content

US FDA Learns 'Lessons Of History,' Takes Opioid Fight To Gabapentinoids
Third-Party Payers Denied Class Certification in Neurontin, Vioxx Litigation
Purdue Execs Plead Guilty To Misbranding OxyContin; Company Pays $700 Mil.
Cephalon Marketing Under Investigation By Philadelphia U.S. Attorney
Pfizer To Monitor Off-Label Drug Use Under Neurontin Settlement
Rx Comparative Studies Will Be Funded By Neurontin Settlement
Rx Comparative Studies Will Be Funded By Neurontin Settlement
Pfizer To Monitor Off-Label Drug Use Under Neurontin Settlement
Neurontin Ruling Is Guide For DoJ Off-Label Promotion Cases – Prosecutor
WARNER-LAMBERT FAJARDO, P.R. PLANT TO BE TAKEN OFF FDA INTEGRITY POLICY SOON, FIRM SAYS; FAILURE TO REPORT DILANTIN TEST FAILURES PROMPTS GUILTY PLEA
Advertisement
UsernamePublicRestriction

Register

PS043997

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel